title: Estrogens modulate RANKL-RANK/osteoprotegerin mediated interleukin-6 effect on thyrotoxicosis-related bone turnover in mice.
abstract: Interleukin-6 has been shown to cause imbalance between bone resorption and formation in thyrotoxicosis. The aim of the present study was an attempt to estimate the influence of estrogens on thyrotoxicosis-related disturbances in bone turnover in relation to RANKL-RANK/osteoprotegerin system in IL-6 deficient mice. The study was performed on 56, 12-13 weeks old, female mice: C57BL/6J (wild-type; WT) and C57BL/6J (IL6-/-Kopf) (IL-6 knock-out; IL6KO). The mice were randomly divided into 8 groups with 7 mice in each one: 1. WT controls, 2. IL6KO controls, 3. WT mice with thyrotoxicosis, 4. IL6KO mice with thyrotoxicosis, 5. WT ovariectomized, 6. IL6KO ovariectomized, 7. WT ovariectomized mice with thyrotoxicosis, and 8. IL6KO ovariectomized mice with thyrotoxicosis. Experimental model of menopause was evoked by bilateral ovariectomy carried out in 8-9 weeks old mice. Thyrotoxicosis was induced by intraperitoneal injection of levothyroxine at a dose of 1 μg/g daily over 21 days. The serum levels of TRACP5b, osteocalcin, OPG, and RANKL were determined by ELISA. RANKL serum concentrations were elevated significantly in all groups of ovariectomized mice as compared to respective controls, however, in a minor degree in IL6KO thyrotoxic mice as compared to wild-type animals. Osteoprotegerin serum levels were significantly increased in all thyrotoxic groups of mice except ovariectomized IL6KO animals. To sum up, the results of the present study suggest that IL-6 plays a key role in stimulation of RANKL-RANK/OPG system and this effect is strongly enhanced in conditions of accelerated bone turnover such as thyrotoxicosis and/or estrogen depletion.
authors.affiliation: Department of Endocrinology, Diabetology and Internal Diseases, Medical University of Bialystok, Bialystok, Poland. janusz.mysliwiec@umwb.edu.pl
authors.forename: J
authors.initials: J
authors.lastname: Mysliwiec
authors.forename: R
authors.initials: R
authors.lastname: Zbucki
authors.forename: A
authors.initials: A
authors.lastname: Nikolajuk
authors.forename: P
authors.initials: P
authors.lastname: Mysliwiec
authors.forename: K
authors.initials: K
authors.lastname: Kaminski
authors.forename: Z
authors.initials: Z
authors.lastname: Bondyra
authors.forename: J
authors.initials: J
authors.lastname: Dadan
authors.forename: M
authors.initials: M
authors.lastname: Gorska
authors.forename: M M
authors.initials: MM
authors.lastname: Winnicka
mesh_terms: D000818:Animals; D015519:Bone Density; D001842:Bone and Bones / Q000502:physiology*; D004195:Disease Models, Animal; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D053245:RANK Ligand / Q000378:metabolism*; D053246:Receptor Activator of Nuclear Factor-kappa B / Q000378:metabolism*; D013971:Thyrotoxicosis / Q000235:genetics / Q000378:metabolism*
chemical_list: D004967:Estrogens; D015850:Interleukin-6; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505687:Tnfrsf11a protein, mouse